Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

Peak of Australian flu season is imminent so take the necessary precautions now: Experts

The Influenza Specialist Group (ISG) is today warning that high rates of influenza outbreaks have been confirmed in QLD, SA and NSW, but there is still time for most Australians, especially those in at-risk groups, to protect themselves and those around them.

18 Jul 2011

Personal health data in Google Health profile can easily be transferred to Microsoft HealthVault account

Microsoft Corp. today announced that people using the Google Health service, scheduled to be discontinued Jan. 1, 2012, can easily transfer their personal health information stored in a Google Health profile to a Microsoft HealthVault account using the Direct Project messaging protocols established by the Office of the National Coordinator for Health IT.

18 Jul 2011

Two existing clinical stage clients expand development activities with Progenitor Cell Therapy

Progenitor Cell Therapy (PCT), an internationally recognized cell therapy services and development company, and a wholly-owned subsidiary of NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced today that two existing clinical stage biopharmaceutical corporate clients have chosen to expand their development activities with PCT.

18 Jul 2011

Tips for preventing allergy during ragweed pollen season

Feel like there's no end in sight when it comes to fall allergy misery? Blame global warming. Research suggests that with global warming, nasal allergy during the ragweed pollen season - also called hay fever or seasonal allergic rhinitis - lasts up to three weeks longer than it used to, and the further north you live, the longer you have to wait for relief.

16 Jul 2011

Partially hydrolysed whey formula does not prevent allergies in high-risk infants

Despite the formula being recommended in public health guidelines set out by the Australasian Society of Clinical Immunology and Allergy, the new study, published online in the Journal of Allergy and Clinical Immunology, found there was no benefit in using hypoallergenic formula to prevent allergies in high-risk infants up to seven years of age, compared to a conventional cow's milk based formula.

15 Jul 2011

NeoStem to acquire Amorcyte

NeoStem, Inc., an international biopharmaceutical company, announced the signing of a definitive merger agreement whereby NeoStem will acquire Amorcyte, Inc., a development stage cell therapy company focusing on novel treatments for cardiovascular disease.

15 Jul 2011

Non-invasive 'swine flu' breath test could help ease future vaccine shortages

A test, novel breath measuring the immune response to the H1N1 flu virus, could help to ease future vaccine shortages by identifying the people who have already been infected with the flu virus.

15 Jul 2011

New paper provides unique review on respiratory disorders in the Middle East

Lung diseases in the Middle East range from the centuries-old pulmonary tuberculosis (TB) to modern manifestations caused by chemical warfare. A new paper now available in Respirology, a journal of the Asian Pacific Society of Respirology, provides pulmonologists and patients with the first comprehensive review of respiratory illnesses specific to the Persian Gulf region, and the challenges in treating them.

14 Jul 2011

European Respiratory Society Congress to take place on September 24, 2011

The 2011 European Respiratory Society Congress will take place at the Amsterdam RAI congress centre from Saturday 24 September to Wednesday 28 September 2011.

14 Jul 2011

IMM researcher wins prestigious Early Career Bayer Hemophilia Award

Vanessa Oliveira, researcher at the Instituto de Medicina Molecular in Portugal won a prestigious and competitive Early Career Bayer Hemophilia Award. Oliveira will develop a strategy to reprogramme the immune system of hemophilia patients to avoid immune targeting of the most used clotting therapeutics.

14 Jul 2011

Dummy inhalers trick asthma patients to breathe easier: Study

A new study shows that dummy pills or placebo can act in asthma patients effectively making them think that real and fake drugs were doing the same level of good, even though the real medication actually had a much greater physical effect on their lungs. The effect was so strong that it convinced patients they were breathing much better even if they hadn't taken a real drug and hadn't actually improved much, as measured by a breathing test.

13 Jul 2011

Johns Hopkins receives NHLBI grant to establish two programs in glycosciences

The National Heart, Lung and Blood Institute, one of the National Institutes of Health, has awarded two groups at the Johns Hopkins University School of Medicine each approximately $2.3 million a year for seven years to establish two Programs of Excellence in Glycosciences.

13 Jul 2011

Hypoallergenic dogs not allergen free as claimed: Study

New research shows that the levels of dog allergens don't appear to be very different in houses with hypoallergenic dogs than in those with other dogs.

13 Jul 2011

One-fifth of all patients with fatal pulmonary disease receive delayed diagnosis

One-fifth of all patients with pulmonary arterial hypertension suffer with the fatal disease for more than two years before being correctly diagnosed and properly treated, according to a new national study led by researchers at Intermountain Medical Center in Salt Lake City.

12 Jul 2011

Secondhand smoke linked to ADHD, learning and behavioral disorders in kids

The latest study shows that secondhand (passive) smoke can contribute to Attention Deficit Hyperactivity Disorder (ADHD) and other learning disabilities in children. The study from the Harvard School of Public Health, shows kids exposed to smoking were 50 percent more likely to develop neurobiological diseases compared to kids not around smoke.

12 Jul 2011

People with long term debilitating physical illness demonstrate mental resilience

People who have a long term debilitating physical illness demonstrate mental resilience according to Understanding Society, the world's largest longitudinal household study. The first findings reveal that people diagnosed with cancer, diabetes, respiratory or cardiovascular disease report similar mental health scores to those without physical illness.

11 Jul 2011

State roundup: Recurring SustiNet rumors in Conn.

The tentative concession deal negotiated between Gov. Dannel P. Malloy's administration and state employee unions is dead. But suspicions it was linked the SustiNet plan to create state-run insurance live on, complicating chances of striking a new deal to avert up to 6,500 layoffs. ... One simple, incontrovertible fact is that there is no SustiNet coverage plan into which state employees can be enticed or forced. But from there, the picture gets fuzzy.

11 Jul 2011

iBio successfully produces human plasma proteins using proprietary technology

iBio, Inc. today announced successful production of human plasma proteins using its proprietary iBioLaunch technology. Human alpha 1-antitrypsin and human C1 esterase inhibitor were successfully produced at high yield in green plants via the Company's proprietary iBioLaunch technology. Both of these proteins are important therapeutic products, but until now they have been made from human blood.

11 Jul 2011

People with long term debilitating physical illness demonstrate mental resilience

People who have a long term debilitating physical illness demonstrate mental resilience according to Understanding Society, the world's largest longitudinal household study.

11 Jul 2011

German Court announces negative decision regarding validity of Aerocrine patent

Aerocrine AB today announced a negative decision by the Munich Court regarding the validity of one German Aerocrine patent. This decision does not influence Medisoft's obligation to respect the existing three courts decisions in Germany.

8 Jul 2011